SOWJANYA REGANTI M.D. NPI 1356482020

NPI Information

  • NPI: 1356482020
  • Provider Name: SOWJANYA REGANTI, M.D.,
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 5423 RENO CORPORATE DR.
    RENO, NV
    ZIP 89511
  • Phone: (775) 329-0873

Map and Directions

Get Directions

NPI Details

Sowjanya Reganti, M.D., is a hematology and oncology internal medicine in Reno, NV with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Sowjanya Reganti, M.D., NPI is 1356482020. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

5423 RENO CORPORATE DR.
RENO, NV
ZIP 89511-250
Phone: (775) 329-0873
Fax: (775) 329-1026

The NPI 1356482020 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, decitabine, 1 mg (HCPCS:J0894)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, pegfilgrastim-cbqv, biosimilar, (udenyca), 0.5 mg (HCPCS:Q5111)
  • Cyclophosphamide, 100 mg (HCPCS:J9070)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Phosphate level (HCPCS:84100)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Magnesium level (HCPCS:83735)
  • Uric acid level, blood (HCPCS:84550)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Red blood count, automated test (HCPCS:85045)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 2/8/2007 and was last updated on 5/22/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology12627NEVADAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.